Ebook Info
- Published:
- Number of pages:
- Format: PDF
- File Size: 33.9873 MB
- Authors: Steven D. Wexner
Description
Organizes the most important information on the treatment of tuberculosis in one volume, focusing on nanotechnology advancements
Reviews
This updated volume provides a concise guide to the pathogenic, therapeutic, and preventative roles of bacteria in urology. New chapters discussing the involvement of the microbiome in the areas of recurrent kidney stone disease, female urology, and prostate cancer are included. The treatment of urosepsis, stone management, genitourinary malignancy, stone sequencing, and the role of microbiome and virome in urology are also covered. The Role of Bacteria in Urology is relevant to both clinicians and scientists interested in the infection of the genitourinary system. –This text refers to the paperback edition. About the Author Dr. Dirk Lange is a microbiologist who earned his Ph.D. in Microbiology and Immunology from the University of Western Ontario (London, Ontario) on understanding the role of the capsular polysaccharide in the pathogenesis of Campylobacter jejuni. Dr. Lange completed his post-doctoral fellowship at The Stone Centre at VGH with Dr. Ben Chew, where he contributed significantly to the area of urinary biomaterial design, providing a basic science perspective to understanding ureteral stent related morbidity. Due to his significant contributions to the research program at the Stone Centre, Dr. Lange was recruited to the Department of Urologic Sciences as an Assistant Professor in 2011, and is also the Director of Basic Science Research at the Stone Centre. Dr. Lange continues to run a research program aimed at studying the role of bacteria in urology, specifically the development of novel therapies for recurrent kidney stone disease based on the intestinal microbiome as well as the development of novel technologies to prevent indwelling device associated urinary tract infections. Dr. Kymora Scotland is the endourology fellow at the Stone Centre of the Department of Urologic Sciences at the University of British Columbia. Dr. Scotland is a graduate of the Tri-Institutional Cornell/Rockefeller/Sloan Kettering MD-PhD Program with a background in genitourinary pharmacology and molecular biology. She then completed her urology residency at Thomas Jefferson University Hospital where her clinical research concentrated on the endourologic management of kidney stones and upper tract urothelial cancer. Her postgraduate work at the Stone Centre has investigated ureteral stent associated urinary tract infections by further elucidating the mechanism of biofilm formation on stents. Future research endeavors will continue to center on translational work that has direct relevance to her patients. Dr. Scotland will explore the effect of the urinary microbiome on genitourinary disease.. –This text refers to the paperback edition.
Free Download
